Endeavor

Can the Herpes Virus Fight Triple-Negative Breast Cancer?

More than 90% of women injected with the virus are alive up to three years later

Following the Science

Five of 10 researchers from MD Anderson joined Dr. Patrick Hwu at Moffitt

Moffitt CEO Focuses Research on Creating ‘Super Soldiers’

Hwu’s lab seeks out new T-cell therapies for some of the toughest cancers

FDA Approves First Immunotherapy for Initial Treatment of Gastric Cancer

Nivolumab combined with chemotherapy led to a 29% reduced risk of death

Obesity Increases Chance Cancer Will Return

New study finds overweight breast cancer survivors are more likely to develop a second cancer

Moffitt Cancer Center Leaders Tour Pasco Expansion Site

Planning underway for 775-acre research and corporate innovation district

Improving Minority Representation in Lung Cancer Screening

Moffitt researchers present study during the American Association of Cancer Research annual meeting

Does Obesity Impact Cancer Survival?

It depends on what type of cancer you have, according to one new study

FDA Approves CAR T to Help Patients with Relapsed Multiple Myeloma

For one patient, the therapy, made available to him through a clinical trial, was his last resort